Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy

Gandara, 1991, Cisplatin Chemoprotection and Rescue: pharmacologic modulation of toxicity., Sem Oncology, 18, 49 Piel, 1974, Effects of cis-diamminedichoroplatinun (NSC - 119875) on hearing function in man., Cancer Chemother Rep, 58, 871 Drescheler, 1989, Role of high-frequency audiometry in the early detection of ototoxicity. II - clinical aspects., Audiology, 28, 211, 10.3109/00206098909081626 McAlpine, 1990, The ototoxic mechanism of cisplatin., Hear Res, 47, 191, 10.1016/0378-5955(90)90151-E Schewetzer, 1993, Cisplatin induced ototoxicity: the effect of pigmentation and inhibitory agents., The Laryngoscope, 103 Ravi, 1995, Mechanism of cisplatin ototoxicity: antioxidant system., Pharmacology & Toxicology, 76, 386, 10.1111/j.1600-0773.1995.tb00167.x Glover, 1986, Phase I/II Trials of WR-2721 and Cisplatin., Int. J. Radiat Oncol Biol Phys, 12, 1509, 10.1016/0360-3016(86)90205-1 Kalaycioglu, 1994, Clinical Status of the new chemoprotective agent amifostine., Oncology, 8, 15 Glover, 1987, WR-2721 and High-dose Cisplatin: an active Combination in the Treatment of Metastatic Melanoma., J Clin Oncol, 5, 574, 10.1200/JCO.1987.5.4.574 Yohas, 1980, Selective Inhibition of the Nephrotoxicity of Cisdichlorodiammineplatinun (II) by WR-2721 Without Altering its Antitumor Properties., Cancer Treat Rep, 64, 57 Mollman, 1988, Cisplatin Neuropathy: risk factors prognosis and protection by WR-2721., Cancer, 61, 2192, 10.1002/1097-0142(19880601)61:11<2192::AID-CNCR2820611110>3.0.CO;2-A Rubin, 1995, Audiological findings in a phase I protocol investigating the effect of WR-2721 high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma., J Laryngol Otol, 109, 744, 10.1017/S0022215100131202 Foster Nora, 1997, Amifostine for Protection From Antineoplastic Drug Toxicity., Am J Health Syst Pharm, 787, 10.1093/ajhp/54.7.787 Ramath, 1997, Phase II evaluation of cisplatin and WR-2721 of refractory metastatic breast cancer., Am J Clin Oncol, 20, 368, 10.1097/00000421-199708000-00009 Church, 1995, The Comparative Effects of Sodium Thiosulfate Diethyldithiocarbamate Fosfomycin and WR-2721 on Ameliorating Cisplatin - induced ototoxicity., Hear Res, 86, 195, 10.1016/0378-5955(95)00066-D Kaltenbach, 1997, Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster., Otolaryngol Head Neck Surg, 117, 493, 10.1016/S0194-5998(97)70020-2 Jero, 2001, The use of Preyer's reflex in evaluation of hearing in mice., Acta Otolaryngol Jul, 121, 585, 10.1080/000164801316878863 Preyer, 1882 He, 1993, Fine structure of the 2F1-F2 acoustic distortion product: changes with primary level., J Acoust Soc Am, 94, 2659, 10.1121/1.407350 Rasmussen, 1993, Clinical significance of relative probe tone levels on distortion products otoacoustic emissions., Scand Audiol, 22, 223, 10.3109/01050399309047473 Lopes Filho, 1995, Produtos de distorção das emissões otoacústicas., Rev Brasileira de Otorrinolaringologia, 61, 485 Saito, 1994, Comparative ototoxicity of cisplatin during acute and chronic treatment., ORL J Otorhinolaryngol Relat Spec, 56, 315, 10.1159/000276683 Cardinaal, 2000, Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea., Hearing Res, 144, 135, 10.1016/S0378-5955(00)00059-9 Demarco, 2001, Uso da gentamicina intra-timpânica para induzir ablação vestibular unilateral em cobaias., Tese de Dissertação de Mestrado FMRP-USP Oliveira, 2002, Autodefesa contra a ototoxicidade de antibióticos aminoglicosídeos., Rev Brasileira de Otorrinolaringologia, 68, 7, 10.1590/S0034-72992002000100002 Vincent, 2003, Use of aminfostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer., 12